HLS.AX
Price:
$1.445
Market Cap:
$1.05B
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1998-08-03
Stock Exchange
ASX
Ticker
HLS.AX
According to Healius Limited’s latest financial reports and current stock price. The company's current ROE is -61.77%. This represents a change of 187.24% compared to the average of -21.50% of the last 4 quarters.
The mean historical ROE of Healius Limited over the last ten years is -8.97%. The current -61.77% ROE has changed 588.76% with respect to the historical average. Over the past ten years (40 quarters), HLS.AX's ROE was at its highest in in the December 2021 quarter at 12.04%. The ROE was at its lowest in in the December 2023 quarter at -60.54%.
Average
-8.97%
Median
0.90%
Minimum
-62.05%
Maximum
16.02%
Discovering the peaks and valleys of Healius Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.11%
Maximum Annual ROE = 16.02%
Minimum Annual Increase = -1848.30%
Minimum Annual ROE = -62.05%
Year | ROE | Change |
---|---|---|
2024 | -62.05% | 149.51% |
2023 | -24.87% | -255.22% |
2022 | 16.02% | 581.00% |
2021 | 2.35% | -164.46% |
2020 | -3.65% | -233.94% |
2019 | 2.73% | 1.11% |
2018 | 0.23% | -100.81% |
2017 | -27.67% | -1848.30% |
2016 | 1.58% | -72.01% |
2015 | 5.66% | 16.97% |
The current ROE of Healius Limited (HLS.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.63%
5-year avg
-14.44%
10-year avg
-8.97%
Healius Limited’s ROE is less than Viva Energy Group Limited (7.75%), greater than Fletcher Building Limited (-8.55%), less than Cleanaway Waste Management Limited (5.25%), less than IDP Education Limited (24.76%), less than ARB Corporation Limited (15.86%),
Company | ROE | Market cap |
---|---|---|
7.75% | $4.21B | |
-8.55% | $2.68B | |
5.25% | $6.14B | |
24.76% | $3.46B | |
15.86% | $3.34B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Healius Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Healius Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Healius Limited's ROE?
How is the ROE calculated for Healius Limited (HLS.AX)?
What is the highest ROE for Healius Limited (HLS.AX)?
What is the 3-year average ROE for Healius Limited (HLS.AX)?
What is the 5-year average ROE for Healius Limited (HLS.AX)?
How does the current ROE for Healius Limited (HLS.AX) compare to its historical average?